Message to surgeons: The expected norm in elective complex GI cancer surgery is use of perioperative immunonutritional therapy that also saves hospital costs!

Annals of Surgery

Volumn 249, Issue 3, 2009, Pages 364-365

  Meguid, Michael M ^a   Goncalves, Carolina G ^b  

^a SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^b POSITIVO UNIVERSITY   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; ARGININE; CYTOKINE; DOCOSAHEXAENOIC ACID; GLUTAMINE; ICOSAPENTAENOIC ACID; NUCLEOTIDE; OMEGA 3 FATTY ACID;

ANIMAL FOOD; ANOREXIA; CACHEXIA; CANCER PATIENT; CANCER SURGERY; CEREAL; COST CONTROL; DIET THERAPY; DIGESTIVE SYSTEM CANCER; EDITORIAL; EGG; ENTERIC FEEDING; HIGH RISK PATIENT; HOSPITAL COST; HUMAN; IMMUNOTHERAPY; IMPEDANCE; INFLAMMATION; LEAN BODY WEIGHT; MALNUTRITION; MORTALITY; NITROGEN BALANCE; NUTRITIONAL SUPPORT; ORANGE JUICE; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SURGEON; TOTAL BODY WATER; ABDOMINAL SURGERY; DIET SUPPLEMENTATION; DRUG EFFECT; ELECTIVE SURGERY; METABOLISM; METHODOLOGY; NOTE;

DIETARY SUPPLEMENTS; DIGESTIVE SYSTEM SURGICAL PROCEDURES; EICOSAPENTAENOIC ACID; HUMANS; METABOLISM; NUTRITIONAL SUPPORT; PERIOPERATIVE CARE; SURGICAL PROCEDURES, ELECTIVE;

EID: 63449130688     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0b013e31819ab8ba     Document Type: Editorial

References (10)

1. Ryan A, Reynolds JV, Healey L, Byrne M, Moore J, Brannelly N, McHugh A, McCormack D, Flood P. Enteral Nutrition Enriched with Eicosapentaenoic Acid (EPA) Preserves Lean Body Mass Following Esophageal Cancer Surgery: Results of a Double-Blinded Randomized Controlled Trial. Annals of Surgery. 2009;249:355-363.
2. Warren S. The Immediate Causes of Death in Cancer. Am J Med Sci. 1932;184:610.
3. Studley HO. Percentage of Weight Loss as a Predictor of Surgical Risk. JAMA 1936;106(6):458-460.
4. Meguid MM, Debonis D, Meguid V, Hill LR, Terz JJ. Complications of Abdominal Operations for Malignant Disease. Am J Surg. 1988;156:341-345.
5. Heyland DK, Novak F, Drover JW, Jain M, Su X, Suchner U. Should Immunonutrition Become Routine in Critically Ill Patients? JAMA. 2001;286: 944-953.
6. ESPEN Guidelines on Enteral Nutrition: Surgery Including Organ Transplantation. 2006. www.espen.org.
7. Tisdale MI. Inhibition of Lipolysis and Muscle Protein Degradation by EPA in Cancer Cachexia. Nutrition. 1996;12:S31-S33.
8. Fearon KCH, Von Meyenfeldt MF, Moss AG, et al. Effect of Protein and Energy Dense N-3 Fatty Acid Enriched Oral Supplements on Loss of Weight and Lean Tissue in Cancer Cachexia: A Randomized Double Blind Trial. Gut. 2003;52:1479-1486.
9. Heller AR, Rosseler AR, Litz RJ, et al. Omega-3 Fatty Acids Improve the Diagnostic-Related Clinical Outcome. Crit Care Med. 2006;34:972-979.
10. Braga M, Gianotti l, Vignali A, Schmid A, Nespoli L, DiCarlo V. Hospital Resources Consumed for Surgical Morbidity: Effect of Preoperative Argenine and ω-3 Fatty Acid Supplementation on Cost. Nutrition. 2005; 21:1078-1086.